GB1141702A - Therapeutic compositions - Google Patents

Therapeutic compositions

Info

Publication number
GB1141702A
GB1141702A GB4586/66A GB458666A GB1141702A GB 1141702 A GB1141702 A GB 1141702A GB 4586/66 A GB4586/66 A GB 4586/66A GB 458666 A GB458666 A GB 458666A GB 1141702 A GB1141702 A GB 1141702A
Authority
GB
United Kingdom
Prior art keywords
therapeutic compositions
feb
compositions
peroxide
heuprophax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4586/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lab Heuprophax S A
Original Assignee
Lab Heuprophax S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Heuprophax S A filed Critical Lab Heuprophax S A
Publication of GB1141702A publication Critical patent/GB1141702A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB4586/66A 1965-02-03 1966-02-02 Therapeutic compositions Expired GB1141702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR4220A FR4281M (OSRAM) 1965-02-03 1965-02-03

Publications (1)

Publication Number Publication Date
GB1141702A true GB1141702A (en) 1969-01-29

Family

ID=8569897

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4586/66A Expired GB1141702A (en) 1965-02-03 1966-02-02 Therapeutic compositions

Country Status (4)

Country Link
BE (1) BE675829A (OSRAM)
FR (1) FR4281M (OSRAM)
GB (1) GB1141702A (OSRAM)
MY (1) MY6900328A (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2517203A1 (fr) * 1981-12-01 1983-06-03 Wolff Chem Pharm Gmbh Composition pour le traitement de l'acne
US5028414A (en) * 1987-07-17 1991-07-02 The Procter & Gamble Company Anaerobe-selective antibacterial compositions and methods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2517203A1 (fr) * 1981-12-01 1983-06-03 Wolff Chem Pharm Gmbh Composition pour le traitement de l'acne
US5028414A (en) * 1987-07-17 1991-07-02 The Procter & Gamble Company Anaerobe-selective antibacterial compositions and methods

Also Published As

Publication number Publication date
FR4281M (OSRAM) 1966-07-11
MY6900328A (en) 1969-12-31
BE675829A (OSRAM) 1966-06-16

Similar Documents

Publication Publication Date Title
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
US2890984A (en) Pharmaceutical composition containing 2-(1, 2, 3, 4-tetrahydro-1-naphthyl)imidazo-line
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
GB1380171A (en) Medicinal tablets
US3230142A (en) Oral contraceptive compositions and methods
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
GB1141702A (en) Therapeutic compositions
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
DE59108104D1 (de) Arzneimittel enthaltend cd14
GB1474749A (en) Pharmaceutical preparations based on cyproterone
GB1483650A (en) Pharmaceutical preparations based on mesterolone
US3624203A (en) Pharmaceutical contraceptive preparation
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
GB1141214A (en) New derivatives of proscillaridin a
FR2424027A1 (fr) Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant
US3852456A (en) Method for controlling psoriasis
IL43236A (en) 15alpha,16alpha-methylene-19-nor-delta4-pregnene-3,20-diones
Campbell et al. An uncontrolled clinical trial with clomipramine in the treatment of depressed patients.
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
GB1176049A (en) N-Substituted Noratropinium Salts
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB1449043A (en) Treatment of asthma
GB1463260A (en) Pharmacologically active acetic acid derivative